Med-X, Inc. is a Nevada corporation incorporated in February 2014. Initially, it aimed to engage in publishing cannabis-related content, wholesaling cannabis, supplying agricultural products, and developing medicinal supplements. Currently, the company focuses on supplying environmentally friendly health and wellness products through divisions such as Nature-Cide, Thermal-Aid, Malibu Brands, and Advertising. Additionally, it operates the MJT Network, an online media platform about the cannabis industry. Due to regulatory constraints, operations related to cannabis have not fully materialized, yet the company continues to explore opportunities in health and wellness and pest control services.
The company generates revenue primarily through the sales of its products in four divisions: Nature-Cide, Thermal-Aid, Malibu Brands, and Advertising. Nature-Cide and Thermal-Aid are significant contributors to revenue, making up a majority of sales from 2020 to 2021. The MJT Network also contributes to revenue through advertising.
Not disclosed in the provided filing text.
This summary is generated automatically from the company's own filing and may contain errors or omissions. It is a reading aid, not a substitute for the filing itself, and it is not advice.
Underwriters on the deal include EF Hutton, division of Benchmark Investments, LLC. MED-X, Inc. is headquartered in United States and incorporated in NV. It is classified under Agricultural Chemicals.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with MED-X, Inc..
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/med-x" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="MED-X, Inc. — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/med-x?theme=light as the src instead.
https://www.discoveripo.com/ipo/med-x/opengraph-image
MED-X, Inc. IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/med-x?utm_source=embed&utm_medium=text&utm_campaign=med-x
Get emailed when MED-X, Inc.'s terms, price, or expected date change — no weekly noise, just this company.
Registration statement filed with the U.S. Securities and Exchange Commission. Retrieved Oct 15, 2026.
View the original filing on SEC EDGAR →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy